Five weeks of treatment with the GLP-1 analogue liraglutide improves glycaemic control and lowers body weight in subjects with type 2 diabetes. (Q47317632)
Jump to navigation
Jump to search
scientific article published in September 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Five weeks of treatment with the GLP-1 analogue liraglutide improves glycaemic control and lowers body weight in subjects with type 2 diabetes. |
scientific article published in September 2006 |
Statements
1 reference
Five weeks of treatment with the GLP-1 analogue liraglutide improves glycaemic control and lowers body weight in subjects with type 2 diabetes. (English)
1 reference
1 reference
J Gumprecht
1 reference
M A Nauck
1 reference
R Filipczak
1 reference
T D T Le
1 reference
M Zdravkovic
1 reference
NN2211-1499 Study Group
1 reference
1 September 2006
1 reference
114
1 reference
8
1 reference
417-423
1 reference
Identifiers
1 reference
1 reference